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Introduction
　Several studies reported the association between uric 
acid and carotid atherosclerosis [1,2], the latter being a 
known risk factor for stroke [3]. Moreover, several studies 
have identified an inverse association between height and 
stroke [4,5]. Finally, a previous study of ours found a posi-
tive association between height and hyperuricemia [6]. 
However, no published study has investigated the possible 
associations between hyperuricemia and carotid atheroscle-
rosis, while taking body height into account.
　For such an investigation, however, women might not be 
suitable subjects because height is confounded by vertebral 
compression fractures, which are mainly caused by post-
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　Background; Several studies have identified a positive, independent association between uric acid and atherosclerosis 
whereas uric acid was once considered to be a major antioxidant in human plasma with possible beneficial anti-atherosclerotic 
effects. Several other studies have found an inverse association between height and stroke, while a previous study of ours de-
tected a positive association between height and hyperuricemia. However, even though uric acid levels may be strongly affected 
by alcohol consumption and serum creatinine, no published study has examined the possible associations between hyperurice-
mia and carotid atherosclerosis while taking both height and drinking status into account.
　Methods; We conducted a cross-sectional study of 1,337 men aged 30-89 years undergoing a general health check-up to 
investigate the associations of hyperuricemia and carotid atherosclerosis with height in relation to drinking status.
　Results; Of the total study population, 312 men were diagnosed with carotid atherosclerosis (carotid intima-media thickness 
(CIMT) ≥1.1 mm) and 365 men with hyperuricemia (serum uric acid>7.0mg/dL). For shorter non-drinkers, a significantly positive 
association between these two abnormalities was detected, which was independent of classical cardiovascular risk factors ex-
cept for serum creatinine. However, this association ceased to exist after further adjustment for serum creatinine. However, while 
the age-adjusted model showed no significant association for taller drinkers, adjustment for serum creatinine produced a signifi-
cantly inverse association.
　Conclusion; Our study established that hyperuricemia is associated with carotid atherosclerosis for Japanese men, while 
body height, drinking status and serum creatinine are important determining factors for this association.
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menopausal osteoporosis [7]. We therefore limited our in-
vestigation to Japanese men. Other studies have found that 
alcohol consumption is associated with uric acid level [8] 
whereas while light to moderate alcohol consumption re-
portedly has a beneficial effect on atherosclerosis [9]. Since 
the prevalence of drinkers is high among Japanese men, 
[10,11], a study to investigate associations between hyperu-
ricemia and carotid atherosclerosis in relation to body height 
of Japanese men should also take drinking status into ac-
count. To investigate those associations we conducted a 
cross-sectional study of Japanese men who participated in a 
general health check-up between 2005 and 2012.
Methods
Participants
　The survey population included 1,538 men aged 30 to 89 
years, all residents of the western rural Japanese community 
of the Goto Islands, who underwent a general health check-
up between 2005 and 2012. A total of 45 individuals with 
missing data and 156 individuals with a history of cardio-
vascular disease were excluded, leaving 1,337 men for en-
rolment in this study. The mean age of the study population 
was 64.8 years (±10.7 SD; range 30-89). Written consent 
forms were available in Japanese to ensure comprehensive 
understanding of the study objectives, and informed con-
sent was signed by the participants. This study was ap-
proved by the Ethics Committee for Use of Humans of Na-
gasaki University (project registration number: 0501120073). 
Data collections and laboratory measurements
　Body weight and height were measured with an automat-
ic body composition analyzer (BF-220; Tanita, Tokyo, Ja-
pan) when blood was drawn.
　Fasting blood samples were obtained and the serum was 
separated and centrifuged after blood coagulation. Serum 
samples were also obtained in individual siliconized tubes.
　Serum triglycerides, serum HDL cholesterol, serum as-
partate aminotransferase (AST), serum uric acid, HbA1C, 
and serum creatinine levels were measured with standard 
laboratory procedures. 
　Trained interviewers obtained information on smoking 
status, drinking status, medical history, use of antihyper-
tensive agents, medication for diabetes mellitus, and medi-
cation for dyslipidemia. HbA1c, as defined by the National 
Glycohemoglobin Standardization Program (NGSP), was 
calculated with the following equation, which was recently 
proposed by a working group of the Japanese Diabetes So-
ciety (JDS): HbA1c (NGSP) = HbA1c (JDS) + 0.4%. Presence 
of diabetes was defined as HbA1c (NGSP) ≥ 6.5%, and/or 
initiation of glucose-lowering medication or insulin therapy 
[12]. Hyperuricemia was defined as a serum uric acid level 
>7mg/dL [13].
Carotid B-mode ultrasound imaging
 
　Measurement of carotid intima-media thickness (CIMT) 
by ultrasonography of the left and right carotid arteries was 
performed by two medical doctors (N.T. and M.N.) using a 
LOGIQ Book XP with a 10-MHz transducer (GE Health-
care, Milwaukee, WI, USA). The protocol they used has 
been described in detail elsewhere [14]. The values of right 
and left CIMT without measurement of plaque were calcu-
lated and the higher CIMT value was used for analysis. 
Since a previous study reported normal CIMT value as 
<1.1mm, we defined atherosclerosis as CIMT≥1.1mm [15]. 
Intra-observer variation for CIMT (N.T.; n=32) was 0.91 
(p<0.01), and interobserver variation (N.T. and M.N.; n=41) 
was 0.78 (p<0.01).
Statistical analysis
　Differences in age-adjusted mean values or prevalence of 
potential confounding factors by height tertile were calcu-
lated by using covariance or general linear models, while 
logistic regression models were used for calculating odds 
ratios (OR) and 95% confidence intervals (CI) for the asso-
ciation of carotid atherosclerosis with hyperuricemia strati-
fied by height level. In addition, subjects were stratified by 
drinking status because alcohol consumption not only influ-
ences uric acid levels [8] and development of hyperuricemia 
[16], but also atherosclerosis [9].
　A previous study of ours found that height is positively 
associated with hyperuricemia independently from classi-
cal cardiovascular factors including serum creatinine [6], 
while another study of a community based population re-
ported that uric acid may be related to glomerular damage 
[17]. So we established four types of adjusted models. For 
total subjects and non-drinkers, they were an age-adjusted 
model, a multivariable adjusted model that included smok-
ing status (never smoker, former smoker, current smoker), 
alcohol consumption [non-drinker, current light to moder-
ate drinker (1-6 times/week), current heavy drinker (every 
day)], body mass index (kg/m2), diabetes mellitus (no, yes), 
systolic blood pressure (mmHg), antihypertensive medica-
tion use (no, yes), antihyperlipidemic agent use (no, yes), 
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serum triglycerides (mg/dL), serum HDL cholesterol (mg/
dL), and serum AST (IU/L), and a fully adjusted model with 
the addition of serum creatinine (mg/dL). For drinkers, they 
were an age-adjusted model, an age-and-serum creatinine 
adjusted model, and a fully adjusted model that included the 
same variables as those of the fully adjusted model for total 
subjects and non-drinkers.
　All statistical analyses were performed with the SAS sys-
tem for Windows (version 9.3; SAS Inc., Cary, NC). All p-
values for statistical tests were two-tailed, and values of 
<0.05 were regarded as statistically significant.
Results
　Of the 1,337 men taking part in the general health check-
up program, 312 were diagnosed with carotid atherosclero-
sis (carotid intima-media thickness (CIMT) ≥1.1 mm) and 
365 with hyperuricemia (serum uric acid>7.0 mg/dL). Prev-
alence of current drinkers was 50.6%. Table 1 shows age-
adjusted characteristics for this study population in relation 
to body height. The height tertiles were ̒shorter :̓ 155.9±3.7cm 
(<160.1cm;median:157cm),  ̒ intermediateʼ:  163.1±1.6cm 
(160.1-165.8cm;median:163.0cm),̒ taller :̓170.2±3.6(>165.8
cm;median:169.3cm). Current drinker, serum uric acid, and 
serum creatinine were significantly positively associated 
with body height. 
　As shown in Table 2, no significant associations between 
hyperuricemia and carotid atherosclerosis were observed 
for participants of either ʻshorterʼ or ʻintermediateʼ height. 
For ʻtallerʼ participants, no significant associations were 
noted in either the age-adjusted or the multivariable adjust-
ed except for serum creatinine model, but after further ad-
justment for serum creatinine, a significantly inverse asso-
ciation was observed.
　When the analysis of the above associations was limited 
to non-drinking men, the age-adjusted model and the multi-
variable adjusted except for serum creatinine model showed 
a significantly positive association between hyperuricemia 
and carotid atherosclerosis for ʻshorterʼ participants but no 
significant associations were observed for ʻintermediateʻ 
and ʻtallerʻ participants. However, when further adjustment 
was made for serum creatinine, the significant association 
for ʻshorterʻ men ceased to exist (Table 3).
　Table 4 shows the associations between hyperuricemia 
and carotid atherosclerosis for drinking men. The age-ad-
justed model showed no significant association for any of 
the height tertiles. However, when further adjustment was 
made for serum creatinine, a significantly inverse associa-
tion was observed for ʻtallerʻ participants, but no significant 
associations for either ̒ intermediateʻ or ̒ shorterʻ participants. 
These association remained even after further adjustments 
for other classical cardiovascular disease risk factors.
Table 1. Age-adjusted  clinical characteristics of the study population  by height tertiles
Height tertiles




Systolic blood pressure, mmHg
Diastolic blood pressure, mmHg
Antihypertensive medication, %
Body mass index, kg/m2
Serum HDL-cholesterol, mg/dL 
Serum triglycerides, mg/dL
Serum uric acid, mg/dL
Diabetes, % 
Current drinker, % 
Current smoker, % 



























































Age: mean ± standard deviation. Height tertiles: <160.1cm, 160.1-165.8cm, >165.8cm.
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Table 2. Odds ratios (ORs) and 95% CI for atherosclerosis by height tertiles
Shorter Intermediate Taller
Hyperuricemia Hyperuricemia Hyperuricemia
(-) (+) p (-) (+) p (-) (+) p
Atherosclerosis (CIMT ≥ 1.1 mm)
　　　　　　No. at risk 352 105 306 122 314 138
　　　　　　No. of cases
98 (27.8) 39 (37.1) 75 (24.5) 31 (25.4) 53 (16.9) 16 (11.6)
　　　　　　(percentages)
　　　　　　Age-adjusted OR 1.00 1.61 (0.99-2.63) 0.055 1.00 1.07 (0.65-1.77) 0.796 1.00 0.64 (0.35-1.18) 0.150 
　　　　　　Multivariable OR 1.00 1.48 (0.88-2.48) 0.141 1.00 1.00 (0.59-1.70) 0.997 1.00 0.58 (0.31-1.11) 0.102 
　　　　　　Multivariable OR* 1.00 1.09 (0.62-1.92) 0.765 1.00 0.76 (0.43-1.33) 0.333 1.00 0.49 (0.25-0.95) 0.036 
Multivariable OR: adjusted further for age and body mass index, smoking, alcohol intake, systolic blood pressure, antihypertensive medication, diabetes, antihyperlipidemic 
medication, serum triglycerides, serum HDL cholesterol, and serum aspartate aminotransferase (AST). Multivariable OR*: adjusted further for serum creatinine. Height 
tertiles:<160.1cm, 160.1-165.8cm, >165.8cm.
Table 3. Odds ratios (ORs) and 95% CI for atherosclerosis by height tertiles for non-drinking men.
Shorter Intermediate Taller
Hyperuricemia Hyperuricemia Hyperuricemia
(-) (+) p (-) (+) p (-) (+) p
Atherosclerosis (CIMT ≥ 1.1 mm)
　　　　　　No. at risk 213 52 152 47 141 55
　　　　　　No. of cases
59 (27.7) 22 (42.3) 42 (27.6) 16 (34.0) 22 (15.6) 8 (14.5)
　　　　　　(percentages)
　　　　　　Age-adjusted OR 1.00 2.13 (1.09-4.16) 0.027 1.00 1.30 (0.63-2.70) 0.477 1.00 0.90 (0.37-2.18) 0.814 
　　　　　　Multivariable OR 1.00 2.12 (1.04-4.33) 0.040 1.00 1.31 (0.58-2.94) 0.514 1.00 0.86 (0.32-2.36) 0.772 
　　　　　　Multivariable OR* 1.00 1.32 (0.60-2.88) 0.489 1.00 0.98 (0.41-2.32) 0.960 1.00 0.75 (0.26-2.13) 0.585 
Multivariable OR: adjusted further for age and body mass index, smoking, alcohol intake, systolic blood pressure, antihypertensive medication, diabetes, antihyperlipidemic 
medication, serum triglycerides, serum HDL cholesterol, and serum aspartate aminotransferase (AST). Multivariable OR*: adjusted further for serum creatinine. Height tertiles: 
<160.1cm, 160.1-165.8cm, >165.8cm.
Table 4. Odds ratios (ORs) and 95% CI for atherosclerosis by height tertiles for drinking men.
Shorter Intermediate Taller
Hyperuricemia Hyperuricemia Hyperuricemia
(-) (+) p (-) (+) p (-) (+) p
Atherosclerosis (CIMT ≥ 1.1 mm)
　　　　　 No. at risk 139 53 154 75 173 83
　 　　　　No. of cases(percentages) 39 (28.1) 17 (32.1) 33 (21.4) 15 (20.0) 31 (17.9) 8 (9.6)
　　　　　 Age-adjusted OR 1.00 1.12 (0.54-2.33) 0.766 1.00 0.94 (0.47-1.91) 0.868 1.00 0.49 (0.21-1.16) 0.104 
　　　　　 Age-and-serum creatinine
 　　　　　 adjsuted OR 1.00 1.09 (0.48-2.46) 0.438 1.00 0.74 (0.35-1.57) 0.438 1.00 0.39 (0.16-0.98) 0.046 
　　　　　 Multivariable OR* 1.00 1.04 (0.44-2.49) 0.928 1.00 0.54 (0.24-1.29) 0.142 1.00 0.35 (0.13-0.92) 0.034 
Multivariable OR*: adjusted further for age and body mass index, smoking, alcohol intake, systolic blood pressure, antihypertensive medication, diabetes, antihyperlipidemic 
medication, serum triglycerides, serum HDL cholesterol, and serum aspartate aminotransferase (AST), and serum creatinine. Height tertiles: <160.1cm, 160.1-165.8cm, 
>165.8cm.
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Discussion
　The main findings of the present study were that hyperu-
ricemia is associated with carotid atherosclerosis for Japa-
nese men, and that body height, drinking status and serum 
creatinine are important determining factors for those as-
sociations.
　A previous sex-combined study with 181 participants 
who had undergone transesophageal echocardiography re-
ported that uric acid is independently and positively associ-
ated with subclinical thoracic atherosclerosis [1]. On the 
other hand, the Atherosclerosis Risk in Communities Study 
(ARIC Study) reported that uric acid itself may not be a risk 
factor for atherosclerosis [2]. In fact, two other studies hy-
pothesized that uric acid may provide an antioxidant defense 
in humans, so that it may protect against oxidative stress in 
atherosclerosis [18, 19]. Finally, we reported previously that 
hyperuricemia is positively associated with subclinical ath-
erosclerosis defined as mean carotid intima-media thickness 
(CIMT≥1.1mm) but inversely associated with subclinical 
atherosclerosis defined as maximum carotid intima-media 
thickness (CIMT≥1.1mm). Mean CIMT was calculated as 
the mean of right and left CIMT measurements not includ-
ing carotid plaques. Maximum CIMT was defined as the 
greatest CIMT measurement on either side [20]. This study 
thus indicates that hyperuricemia per se might have a ben-
eficial effect on atherosclerosis prevention whereas a back-
ground of hyperuricemia might mean a risk of atherosclero-
sis.
　In our study, hyperuricemia was positively associated 
with carotid atherosclerosis for non-drinking shorter men, 
but this association no longer existed after further adjusted 
for serum creatinine. And after the same adjustment, hype-
ruricemia proved to be inversely associated with carotid 
atherosclerosis for drinking taller men.  
　The Circulatory Risk in Community Study (CIRCS) 
found a significantly inverse association between height and 
risk for both ischemic and hemorrhagic stroke [4], while an-
other study reported that chronic kidney disease (CKD) was 
a significant risk of ischemic stroke for non-drinking but not 
for drinking men [10]. Since serum creatinine  is reportedly 
not only associated with renal function but also with hype-
ruricemia [21], and carotid atherosclerosis is a known risk 
factor for ischemic stroke [3], hyperuricemia might be as-
sociated with carotid atherosclerosis for shorter non-drink-
ing men and indicate the presence of renal dysfunction. This 
mechanism could explain the fact that, in our study, a sig-
nificant association between hyperuricemia and carotid ath-
erosclerosis was observed for shorter non-drinking men, 
but that this association was no longer observed after fur-
ther adjustment for serum creatinine.
　On the other hand, in our current study we also found 
significant inverse association for taller drinking men be-
tween hyperuricemia and carotid atherosclerosis after ad-
justment for serum creatinine. At the same time, a previous 
study of ours demonstrated height is positively associated 
with hyperuricemia and that this association is independent 
from classical cardiovascular risk factors including serum 
creatinine [6]. The study presented here indicates that for 
taller, but not for shorter, participants the main cause of hy-
peruricemia might be independent from classical cardiovas-
cular risk factors such as renal dysfunction. We therefore 
believe the mechanism underlying this association is that 
the taller participants are characterized by a higher activity 
of purine metabolism than the shorter subjects. 
　Birth weight and height correlate strongly with adult 
height [22], and low birth weight is known to be associated 
with altered renal shape, reduced renal volume, and fewer 
nephrons [23], so that shorter stature may increase the 
chance of kidney malfunction occurring later in life [24]. 
Serum creatinine was found to be associated not only with 
renal function but also with hyperuricemia [21]. In addition, 
because alcohol consumption may activate purine metabo-
lism, hyperuricemia may be partly the result of alcohol con-
sumption [8]. Light to moderate alcohol consumption, on 
the other hand, was reported to have a beneficial effect on 
atherosclerosis [9]. Hyperuricemia in alcohol consumers 
may thus partly reflect this beneficial effect on atherosclero-
sis. This explains why our current study found a significant 
inverse association between hyperuricemia and carotid ath-
erosclerosis only after further adjustment for serum creati-
nine, which reduces the effect of renal dysfunction. Uric 
acid used to be considered a major antioxidant in human 
plasma with possible beneficial anti-atherosclerotic effects 
[25]. However, one study demonstrated that uric acid levels 
were independently positively associated with subclinical 
thoracic atherosclerosis [1]. These contradictory findings 
may be partly explained by the mechanisms identified in 
our study. The report by the ARIC Study that uric acid itself 
may not be a risk factor for carotid atherosclerosis [2] also 
appears to support the existence of such mechanisms.
　Certain potential limitations of this study warrant consid-
eration. Because we did not have access to creatinine clear-
ance data, and estimated GFR is not an effective tool for 
evaluating kidney function for a comparison of associations 
with various body heights [6], we could not perform an 
analysis adjusted for exact and detailed renal function. 
However, our analysis showed serum creatinine is one of 
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the most determinant factors for the association between 
hyperuricemia and carotid atherosclerosis both shorter non-
drinking and taller drinking men. Since the method recently 
proposed by a working group of the Japanese Chronic Kid-
ney Disease Initiative (JCKDI) [26] does not take the influ-
ence of height and weight into account, whereas Horioʼs 
method [27] does, estimated GFR is not an effective tool for 
evaluating kidney function in terms of its association with 
various body heights. However, we also found that serum 
creatinine was a significant determinant of CKD as a risk 
factor for hyperuricemia as ascertained by either JCKDI or 
Horio [6]. Although a similar analysis for never-drinkers 
was not feasible because data for this group were not avail-
able, we discovered a significantly positive association be-
tween hyperuricemia and carotid atherosclerosis for non-
drinking men. While the association between hyperuricemia 
and risk of carotid atherosclerosis was shown to be signifi-
cant for taller drinking men in our study, a previous study 
reported a difference in associations with atherosclerosis 
between light to moderate and heavy drinkers [9]. Further 
investigations with a larger number of participants would be 
necessary to enable us to stratify alcohol status in more de-
tail. We could not access the data for diuretic medication 
use even though they may have affected the serum uric acid 
level. However, our study population consisted of general 
participants without a history of cardiovascular disease, so 
that they were less likely to use diuretic medication. Fur-
thermore, significant associations were also observed even 
after further adjustment for systolic blood pressure and liver 
function (AST).Finally, because this study was cross-sec-
tional, we could not determine any causal relationships.
　In conclusion, we were able to establish that hyperurice-
mia (serum uric acid>7.0mg/dL) is associated with carotid 
atherosclerosis for Japanese men. Moreover, body height, 
drinking status and serum creatinine levels were found to 
be important determining factors for those associations.
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